Progress on the Mitochondrial Permeability Transition Pore: Regulation by Complex I and Ubiquinone Analogs

This review summarizes recent progress on the regulation of the mitochondrial permeabilitytransition pore, an inner membrane channel that may play a role in cell death. We brieflycover its key control points as emerged over the last few years from studies on isolatedmitochondria; and describe in some detail our recent results indicating that the pore is modulatedby the respiratory chain complex I and can be specifically blocked by selected ubiquinoneanalogs. We discuss the potential relevance of these findings for the structural definition ofthe permeability transition pore and illustrate the pharmacological perspectives they offer indiseases where mitochondrial dysfunction is suspected to play a key role.

[1]  K. Tanonaka,et al.  Possible mechanism by which coenzyme Q10 improves reoxygenation-induced recovery of cardiac contractile force after hypoxia. , 1987, The Journal of pharmacology and experimental therapeutics.

[2]  M. Schreier,et al.  Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? , 1993, Transplantation proceedings.

[3]  F. Sparla,et al.  The specificity of mitochondrial complex I for ubiquinones. , 1996, The Biochemical journal.

[4]  A. Crevât,et al.  Action of cyclosporine on mitochondrial calcium fluxes , 1987, Journal of bioenergetics and biomembranes.

[5]  G. Kroemer,et al.  Bcl-2 inhibits the mitochondrial release of an apoptogenic protease , 1996, The Journal of experimental medicine.

[6]  R. Lapidus,et al.  Inhibition by spermine of the inner membrane permeability transition of isolated rat heart mitochondria , 1992, FEBS letters.

[7]  P. Bernardi Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. , 1992, The Journal of biological chemistry.

[8]  P. Bernardi,et al.  Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore. I. Evidence for two separate Me2+ binding sites with opposing effects on the pore open probability. , 1993, The Journal of biological chemistry.

[9]  A. Vinogradov,et al.  Slow active/inactive transition of the mitochondrial NADH-ubiquinone reductase. , 1990, Biochimica et biophysica acta.

[10]  A. Vinogradov Kinetics, control, and mechanism of ubiquinone reduction by the mammalian respiratory chain-linked NADH-ubiquinone reductase , 1993, Journal of bioenergetics and biomembranes.

[11]  P. Bernardi,et al.  Induction of the mitochondrial permeability transition by N-ethylmaleimide depends on secondary oxidation of critical thiol groups. Potentiation by copper-ortho-phenanthroline without dimerization of the adenine nucleotide translocase. , 1998, Biochimica et biophysica acta.

[12]  B. Chernyak,et al.  Selective inhibition of the mitochondrial permeability transition pore at the oxidation‐reduction sensitive dithiol by monobromobimane , 1995, FEBS letters.

[13]  P. Tosi,et al.  Localization of the Bcl-2 protein to the outer mitochondrial membrane by electron microscopy. , 1995, Experimental cell research.

[14]  M. Zoratti,et al.  The mitochondrial permeability transition pore may comprise VDAC molecules , 1993, FEBS letters.

[15]  J. Farber,et al.  Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. , 1993, The Journal of biological chemistry.

[16]  M. Zoratti,et al.  Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. , 1992, The Journal of biological chemistry.

[17]  P. Bernardi,et al.  Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by matrix pH. Evidence that the pore open-closed probability is regulated by reversible histidine protonation. , 1993, Biochemistry.

[18]  M. Beal,et al.  Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects , 1997, Annals of neurology.

[19]  M. Zoratti,et al.  The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A. , 1991, The Journal of biological chemistry.

[20]  R. Haworth,et al.  The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. , 1979, Archives of biochemistry and biophysics.

[21]  G. Crabtree,et al.  Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. , 1989, Science.

[22]  E. Fontaine,et al.  Chemical Modification of Arginines by 2,3-Butanedione and Phenylglyoxal Causes Closure of the Mitochondrial Permeability Transition Pore* , 1998, The Journal of Biological Chemistry.

[23]  M. Beal,et al.  Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice , 1998, Brain Research.

[24]  P. M. Sokolove,et al.  The mitochondrial permeability transition. Interactions of spermine, ADP, and inorganic phosphate. , 1994, The Journal of biological chemistry.

[25]  N. Price,et al.  cDNA cloning of rat mitochondrial cyclophilin. , 1997, Biochimica et biophysica acta.

[26]  F. Nicoletti,et al.  Ubiquinone Protects Cultured Neurons against Spontaneous and Excitotoxin-Induced Degeneration , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  B. Chernyak,et al.  Modulation of the Mitochondrial Permeability Transition Pore by Pyridine Nucleotides and Dithiol Oxidation at Two Separate Sites (*) , 1996, The Journal of Biological Chemistry.

[28]  A. Vinogradov,et al.  Effect of Ca2+ ions on the slow active/inactive transition of the mitochondrial NADH-ubiquinone reductase. , 1992, Biochimica et biophysica acta.

[29]  K. Kristensson,et al.  Lipid Compositions of Different Regions of the Human Brain During Aging , 1990, Journal of neurochemistry.

[30]  M. Zoratti,et al.  Modulation of the mitochondrial megachannel by divalent cations and protons. , 1992, The Journal of biological chemistry.

[31]  A. Schapira,et al.  Mitochondrial dysfunction in neurodegenerative disorders. , 1998, Biochimica et biophysica acta.

[32]  J. Crestanello,et al.  Elucidation of a tripartite mechanism underlying the improvement in cardiac tolerance to ischemia by coenzyme Q10 pretreatment. , 1996, The Journal of thoracic and cardiovascular surgery.

[33]  G. Miotto,et al.  Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. , 1999, Biophysical journal.

[34]  P. Bernardi,et al.  On the effects of paraquat on isolated mitochondria. Evidence that paraquat causes opening of the cyclosporin A-sensitive permeability transition pore synergistically with nitric oxide. , 1995, Toxicology.

[35]  M. L. Genova,et al.  Major changes in complex I activity in mitochondria from aged rats may not be detected by direct assay of NADH:coenzyme Q reductase. , 1995, The Biochemical journal.

[36]  A. Halestrap,et al.  Chaotropic agents and increased matrix volume enhance binding of mitochondrial cyclophilin to the inner mitochondrial membrane and sensitize the mitochondrial permeability transition to [Ca2+]. , 1996, Biochemistry.

[37]  W. Welte,et al.  Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore , 1996, FEBS letters.

[38]  F. Ichas,et al.  A Ubiquinone-binding Site Regulates the Mitochondrial Permeability Transition Pore* , 1998, The Journal of Biological Chemistry.

[39]  M. Klingenberg,et al.  Immunochemical characterization of the adenine nucleotide translocator. Organ specificity and conformation specificity. , 1984, European journal of biochemistry.

[40]  K. Gunter,et al.  Transport of calcium by mitochondria , 1994, Journal of bioenergetics and biomembranes.

[41]  B. Rosen,et al.  Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate , 1994, Annals of neurology.

[42]  L. Scorrano,et al.  On the Voltage Dependence of the Mitochondrial Permeability Transition Pore , 1997, The Journal of Biological Chemistry.

[43]  Y. Hatefi,et al.  Mitochondrial NADH-Ubiquinone Oxidoreductase (Complex I) , 1998, The Journal of Biological Chemistry.

[44]  W. Catterall,et al.  Structure and function of voltage-sensitive ion channels. , 1988, Science.

[45]  P. Bernardi,et al.  Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. , 1994, Biochimica et biophysica acta.

[46]  J. Schulz,et al.  Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10 , 1994, Neuroscience Letters.

[47]  S. Vries,et al.  The mitochondrial respiratory chain of yeast. Structure and biosynthesis and the role in cellular metabolism. , 1987, Biochimica et biophysica acta.

[48]  A. Bindoli,et al.  Effect of polycation peptides on mitochondrial permeability transition. , 1995, Biochemical and biophysical research communications.

[49]  B. Chernyak,et al.  The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites. , 1996, European journal of biochemistry.

[50]  A. Halestrap,et al.  Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. , 1990, The Biochemical journal.

[51]  A. Sanbe,et al.  Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment. , 1994, The Journal of pharmacology and experimental therapeutics.

[52]  K. Kristensson,et al.  Ubiquinone‐10 Protects Neurons from Virus‐Induced Degeneration , 1994, Journal of neurochemistry.

[53]  P. Bernardi,et al.  Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore. II. The minimal requirements for pore induction underscore a key role for transmembrane electrical potential, matrix pH, and matrix Ca2+. , 1993, The Journal of biological chemistry.

[54]  G. Kroemer,et al.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death , 1995, The Journal of experimental medicine.

[55]  R. Haworth,et al.  The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release. , 1979, Archives of biochemistry and biophysics.

[56]  M. Dempsey,et al.  Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. , 1989, The Journal of biological chemistry.

[57]  K. Kristensson,et al.  Ubiquinone, dolichol, and cholesterol metabolism in aging and Alzheimer's disease. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[58]  C. L. Wadkins,et al.  Factors that influence phosphoenolpyruvate-induced calcium efflux from rat liver mitochondria. , 1974, Biochemical and biophysical research communications.

[59]  A. Halestrap,et al.  Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. , 1998, The Biochemical journal.

[60]  S. Javadov,et al.  Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. , 1998, Biochimica et biophysica acta.

[61]  P. Bernardi,et al.  On the nature of Pi‐induced, Mg2+‐prevented Ca2+ release in rat liver mitochondria , 1982, FEBS letters.

[62]  C. Klocek,et al.  Proton selective substate of the mitochondrial permeability transition pore: regulation by the redox state of the electron transport chain. , 1998, Biochemistry.

[63]  G. Dallner,et al.  Biochemical, physiological and medical aspects of ubiquinone function. , 1995, Biochimica et biophysica acta.

[64]  M. Zoratti,et al.  The mitochondrial permeability transition pore may comprise VDAC molecules , 1993, FEBS letters.

[65]  F. Di Virgilio,et al.  Activation of site I redox-driven H+ pump by exogenous quinones in intact mitochondria. , 1982, The Journal of biological chemistry.

[66]  B. Herman,et al.  Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine. , 1993, The Journal of pharmacology and experimental therapeutics.

[67]  J. Mazat,et al.  Mitochondria Are Excitable Organelles Capable of Generating and Conveying Electrical and Calcium Signals , 1997, Cell.

[68]  D. Pfeiffer,et al.  The relationship between mitochondrial membrane permeability, membrane potential, and the retention of Ca2+ by mitochondria. , 1980, The Journal of biological chemistry.

[69]  P. Bradshaw,et al.  Properties of a Cyclosporin-insensitive Permeability Transition Pore in Yeast Mitochondria* , 1997, The Journal of Biological Chemistry.

[70]  A. Vinogradov,et al.  Catalytic properties of the mitochondrial NADH-ubiquinone oxidoreductase (complex I) and the pseudo-reversible active/inactive enzyme transition. , 1998, Biochimica et biophysica acta.

[71]  M. Beal,et al.  Mitochondrial dysfunction in neurodegenerative diseases. , 1998, Biochimica et biophysica acta.

[72]  A. Koretsky,et al.  The role of creatine kinase in inhibition of mitochondrial permeability transition , 1997, FEBS letters.

[73]  F. Ichas,et al.  Regulation of the Permeability Transition Pore in Skeletal Muscle Mitochondria , 1998, The Journal of Biological Chemistry.

[74]  J. Farber,et al.  The Overexpression of Bax Produces Cell Death upon Induction of the Mitochondrial Permeability Transition* , 1998, The Journal of Biological Chemistry.

[75]  R. Haworth,et al.  The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site. , 1979, Archives of biochemistry and biophysics.

[76]  M. Crompton,et al.  Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. , 1988, The Biochemical journal.

[77]  A. Lehninger,et al.  Rapid efflux of Ca2+ from heart mitochondria in the presence of inorganic pyrophosphate. , 1984, Biochemical and biophysical research communications.

[78]  L. Scorrano,et al.  The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. , 1994, The Journal of biological chemistry.

[79]  M. Zoratti,et al.  The mitochondrial megachannel is the permeability transition pore , 1992, Journal of bioenergetics and biomembranes.

[80]  R. Bohnensack,et al.  Relations between extramitochondrial and intramitochondrial adenine nucleotide systems. , 1981, Archives of biochemistry and biophysics.

[81]  J. Hoek,et al.  Physiological roles of nicotinamide nucleotide transhydrogenase. , 1988, The Biochemical journal.

[82]  S. Metcalfe,et al.  Peptidylproline cis/trans isomerases. , 1995, Progress in biophysics and molecular biology.

[83]  P. Bernardi,et al.  Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane , 1994, Journal of bioenergetics and biomembranes.

[84]  K. Kinnally,et al.  Mitochondrial channel activity studied by patch-clamping mitoplasts , 1989, Journal of bioenergetics and biomembranes.

[85]  H. Schmid,et al.  Intramitochondrial phospholipase activity and the effects of Ca2+ plus N-ethylmaleimide on mitochondrial function. , 1979, The Journal of biological chemistry.

[86]  E. Fontaine,et al.  Inhibition of the mitochondrial cyclosporin A‐sensitive permeability transition pore by the arginine reagent phenylglyoxal , 1997, FEBS letters.

[87]  D. Pfeiffer,et al.  Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases. , 1995, Biochemistry.

[88]  P. Bernardi,et al.  Interactions of Cyclophilin with the Mitochondrial Inner Membrane and Regulation of the Permeability Transition Pore, a Cyclosporin A-sensitive Channel (*) , 1996, The Journal of Biological Chemistry.

[89]  M. Klingenberg,et al.  Demonstration of the relationship between the adenine nucleotide carrier and the structural changes of mitochondria as induced by adenosine 5'-diphosphate. , 1974, Biochemistry.

[90]  M. Crompton,et al.  Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria. , 1987, The Biochemical journal.

[91]  G. Azzone,et al.  The equivalent pore radius of intact and damaged mitochondria and the mechanism of active shrinkage. , 1972, Biochimica et biophysica acta.

[92]  M. Klingenberg,et al.  Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. , 1996, Biochemistry.

[93]  Paolo Bernardi,et al.  The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal , 1996, Journal of bioenergetics and biomembranes.

[94]  M. Zoratti,et al.  The inner mitochondrial membrane contains ion‐conducting channels similar to those found in bacteria , 1989, FEBS letters.